Why Radiation Causes Side Effects — and Why They Vary So Much Between Patients

---

Radiation works by damaging the DNA of cancer cells so they can no longer divide. The problem is that radiation does not have eyes — it damages all cells in the treatment field.

The prostate is surrounded by the bladder above it, the rectum behind it, and the urethra running through its middle.

The bladder, the rectal wall, the urethra, and the nerves responsible for erectile function all sit close enough to the prostate to receive some radiation dose, even with modern precision techniques.

The mission of modern radiation planning — IMRT, VMAT, SBRT, CyberKnife — is to deliver as high a dose as possible to the prostate while keeping the dose to surrounding structures as low as possible.

This mission is never perfectly achievable. But it is far more achievable today than it was twenty years ago.

The degree of side effects varies between patients for several reasons. Prostate size matters — a very large prostate is harder to irradiate without significant dose to adjacent structures.

Pre-existing bowel or urinary conditions matter — a man with inflammatory bowel disease or significant BPH starts with less reserve.

Age and general vascular health matter — older men with diabetes or poor circulation tend to have slower tissue recovery.

The specific radiation technique also matters — SBRT's five-fraction delivery and CyberKnife's real-time tumour tracking allow tighter margins, reducing dose to surrounding tissue compared to conventional EBRT.

Acute Side Effects During EBRT — What Happens Week by Week

---

Acute side effects are those that occur during treatment or within the first three months after it ends. For conventional EBRT — delivered in 20 to 40 daily sessions over four to eight weeks — the acute effects follow a fairly predictable pattern.

Weeks 1–2: Little to nothing

Most men feel entirely normal in the first two weeks of EBRT. The radiation is accumulating in the tissue but the cellular response takes time to build. Some men are surprised to feel no different at all after their first session.

This is the time when it is most important to maintain the bowel preparation protocol — typically a rectal emptying protocol before each session, often involving a micro-enema.

Consistency of rectal filling — keeping the rectum consistently empty and in the same position — is one of the most important factors in reducing rectal dose.

Weeks 3–5: Bladder and bowel symptoms begin

This is when most men start to feel the effects of radiation accumulating. The bladder lining becomes irritated — producing urinary frequency and urgency, including at night.

Passing urine may feel slightly uncomfortable. These symptoms are expected and manageable.

Bowel changes appear in a similar pattern — looser stools or increased frequency are common. Some men notice an uncomfortable sensation in the rectum.

Significant rectal bleeding in the acute phase is uncommon at modern IMRT centres — if it occurs it should be reported to the radiation team immediately.

Fatigue builds gradually across the treatment course. It is not sudden or dramatic — more like a heaviness that accumulates. Most men continue their normal activities throughout the treatment course but find they need more rest in the evenings.

How India's hospitals manage acute EBRT side effects

At Apollo Delhi, Medanta, Max Saket, and Fortis FMRI, patients on EBRT have a weekly review with the radiation oncologist or a dedicated radiotherapy nurse.

This is not a formality — it is the mechanism through which emerging side effects are caught early and managed before they become grade 3.

Alpha-blocker medication — tamsulosin — is prescribed prophylactically at most Indian centres for urinary symptoms.

Anti-diarrhoeal agents, dietary guidance, and topical rectal preparations are prescribed as needed. The goal is to keep acute toxicity at grade 1 to 2 and prevent escalation.

SBRT Side Effects — Does Five Sessions Mean Fewer Side Effects?

---

SBRT delivers the full radiation course in five sessions over one to two weeks. The biological dose per session is significantly higher than in conventional EBRT — which is what makes it clinically equivalent despite fewer sessions.

Patients often expect that fewer sessions must mean fewer side effects. The relationship is more nuanced than that.

SBRT's acute side effects are typically milder during the treatment period itself — simply because the treatment period is so short. Most men feel reasonably normal during the two weeks of SBRT at Kokilaben or Apollo Delhi.

Because each fraction delivers a higher biological dose, the post-treatment inflammatory response can be somewhat more pronounced in the weeks following SBRT.

Some men notice their urinary symptoms peak two to four weeks after completing SBRT — at a point when their conventional EBRT counterpart would be mid-course and just beginning to notice symptoms.

By six months after SBRT, the vast majority of men are back to their pre-treatment baseline for both urinary and bowel function.

The PACE-B trial — which compared SBRT to conventional radiotherapy in a large randomised setting — confirmed that SBRT's two-year toxicity profile was non-inferior to conventional radiation.

For international patients, SBRT has a specific practical advantage beyond side effects: the treatment is complete before you leave India.

You fly home having finished your radiation, rather than managing ongoing acute symptoms during a long-haul flight.

Brachytherapy Side Effects — The First Six Months

---

Brachytherapy — placing radioactive seeds directly inside the prostate — delivers a very high local radiation dose while protecting surrounding structures better than external beam radiation can achieve for the same tumour dose.

The seeds sit inside the prostate. The prostate swells in response to the implant procedure and to the radiation being delivered continuously from within.

This swelling presses on the urethra from inside — producing the most significant acute side effect of brachytherapy: urinary obstructive symptoms.

Urinary symptoms — the main brachytherapy challenge

In the first four to six weeks after LDR seed implant, urinary frequency, urgency, and a weak or stop-start stream are very common.

Alpha-blocker medication — tamsulosin or silodosin — is prescribed from the day of the procedure to reduce the degree of obstruction while the prostate settles.

Some men experience acute urinary retention — a complete inability to urinate — in the first one to two weeks. This occurs in approximately 5 to 15 percent of cases and requires temporary catheterisation.

It is more common in men who already had significant urinary symptoms from BPH before the implant.

This is why men with large prostates — typically above 60 grams — or severe pre-existing BPH symptoms are generally not good candidates for LDR brachytherapy.

A prostate volume measurement and a baseline urinary symptom score should be assessed before brachytherapy is recommended.

By three months after the implant, the prostate swelling has largely resolved and urinary symptoms in most men have improved significantly. By six months, the majority of men are at or near their pre-implant baseline.

Radiation precautions after brachytherapy

After LDR seed implant, the seeds continue to emit low-energy radiation for several months. The radiation travels only a short distance in tissue.

For the first two months after implant, it is advisable to avoid prolonged close contact with pregnant women and young children.

Most radiation oncologists recommend avoiding sitting a child under ten years old on your lap for more than 30 minutes at a time for the first two months.

Maintaining a metre or more of distance from pregnant women when sitting for extended periods is also advised. These precautions are discussed in detail at discharge from any reputable brachytherapy programme.

Erectile Function After Radiation — the Honest Picture

---

Radiation for prostate cancer does not damage the nerves responsible for erections in the same direct way that surgery does. The nerves remain anatomically intact.

What radiation does is damage the small blood vessels in and around the prostate — including those supplying the erectile tissue — gradually and cumulatively.

This means the impact on erectile function after radiation is typically delayed and gradual, rather than immediate. In the months immediately after radiation, most men retain the same level of erectile function they had before treatment.

The decline tends to begin six to twelve months after treatment and continues slowly over the following one to two years.

By five years after radiation, erectile function loss is similar in magnitude to what surgery produces — but the trajectory is different. Surgery's impact is immediate and then recovers; radiation's impact is delayed and then gradually worsens.

Published data from high-quality radiation programmes shows that approximately 50 to 70 percent of men who had satisfactory erections before radiation maintain the ability to have sexual activity — with or without PDE-5 inhibitors — at two years after treatment.

Age is the strongest predictor. Men under 60 with good pre-treatment function fare significantly better than men over 70.

The radiation technique matters at the margin — SBRT and brachytherapy's tighter margins may preserve vascular supply slightly better, though the published difference is not large enough to make technique choice primarily on this basis.

If you are on hormone therapy alongside radiation — standard for intermediate and high-risk disease — ADT suppresses testosterone to near zero and eliminates sexual desire during the treatment period.

Erectile function may recover after ADT stops, but it is slower in men who are older or on ADT for longer periods.

Late Side Effects — What a Minority of Men Experience Years Later

---

Late radiation side effects are those that appear more than three months after treatment ends — sometimes years later. They affect a minority of men. But they are real, they can be significant, and they deserve honest discussion as part of informed consent.

Late radiation cystitis

Late radiation cystitis — inflammation of the bladder wall months or years after radiation — affects approximately 5 to 10 percent of men who received pelvic radiation.

It presents as urinary frequency, urgency, or blood in the urine appearing well after treatment has ended and acute symptoms have resolved.

In most men it is grade 1 to 2 — noticeable but manageable.

In a small minority — under 3 percent at modern centres — it is grade 3 or above, requiring cystoscopy, laser treatment, or in rare cases hyperbaric oxygen therapy. Men with pre-existing bladder conditions are at higher risk.

Late radiation proctitis

Late radiation proctitis — inflammation of the rectal wall — is the most concerning late complication of prostate radiation, and the one that modern IMRT planning specifically tries to minimise.

It presents as rectal bleeding, urgency, or mucus discharge appearing months to years after treatment.

The risk of grade 3 or above late rectal toxicity at modern IMRT centres is below 3 to 5 percent.

Centres that use rectal spacers — a biodegradable hydrogel placed between the prostate and rectum before radiation — reduce rectal dose substantially and bring this risk down further.

Rectal spacers are available at Apollo Delhi, Medanta, and Fortis FMRI. Ask specifically whether a spacer is recommended for your treatment plan — it is not used routinely at every centre but adds meaningful protection for patients at higher rectal risk.

Secondary cancers from radiation

Radiation increases the very small risk of secondary cancers — bladder cancer and rectal cancer — in the years and decades after treatment. The absolute risk is low: approximately 1 in 200 men over a twenty-year period.

For most men — particularly those who are 60 or older — the probability of dying from their prostate cancer before a radiation-induced secondary cancer has time to develop is significantly higher than the risk of the secondary cancer itself.

This consideration is real but should be kept in proportion.

Managing Radiation Side Effects From Home — What Happens After You Leave India

---

For international patients who complete SBRT or brachytherapy in India and return home within two weeks of finishing, some acute side effects may be peaking or just beginning when they arrive home. Knowing what to expect and what needs a local doctor prevents unnecessary anxiety.

GAF Healthcare provides every radiation patient with a side effect management guide written for their local doctor.

It explains which symptoms are expected and self-limiting, which need local medical attention, and which should prompt urgent contact with the Indian radiation oncologist.

Symptoms that are expected and self-limiting

Urinary frequency and urgency in the first six weeks after radiation. Loose stools or increased bowel frequency for the same period. Fatigue that gradually lifts over four to six weeks. Mild rectal discomfort or urgency that resolves without treatment.

These symptoms do not require emergency management at a local hospital. They should be managed with the medications prescribed at discharge — typically alpha-blockers for urinary symptoms, anti-diarrhoeal agents as needed, and dietary modification for bowel symptoms.

Symptoms that need prompt local medical attention

Significant blood in the urine — more than a pink tinge — should be assessed by a local doctor within 24 to 48 hours. Significant rectal bleeding — bright red blood on more than two occasions — similarly. Inability to urinate requires same-day emergency attention.

Any sign of a urinary tract infection — fever with urinary symptoms, burning, cloudy urine, or rigors — should be treated promptly with antibiotics rather than waiting.

A urine culture and local antibiotic treatment is appropriate. Inform your Indian radiation oncologist at the same time.

Your Indian radiation oncologist conducts a video follow-up consultation at six weeks and three months after you return home.

PSA monitoring begins three months after treatment. The PSA nadir from radiation is reached gradually over 18 to 36 months, so early PSA readings after radiation are not interpreted the same way as PSA after surgery.

Frequently Asked Questions

---